# Day 3 Task Log

## Date

Day 3

## Main Objective

The objective of Day 3 was to refactor the project into a config-driven pipeline and extend the prototype from baseline reporting into efficacy analysis reporting

Day 1 established the first end-to-end mapping pipeline  
Day 2 added human-in-the-loop review QC and audit logic  
Day 3 added configurable pipeline control and the first efficacy analysis layer

---

## Pipeline Status After Day 3

```text
Raw CSV
→ Metadata Scanner
→ Semantic Matcher
→ Human-in-the-loop Mapping Review
→ Manual Override
→ Mapping QC Report
→ Data Quality Report
→ Mapping Config JSON
→ ADSL-like Dataset
→ ADEFF-like Dataset
→ Primary Endpoint Summary Table
→ Treatment Difference Table
→ Exploratory Welch t-test Table
→ Table 1
→ Mini CSR-style Report
```

---

## Completed Tasks

### 1. Refactored Pipeline to Use config.yaml

Updated

```text
config.yaml
```

Moved hard-coded paths and parameters out of

```text
main.py
```

The following items are now controlled by config

```text
raw_data_path
mapping_config_path
mapping_qc_output_path
data_quality_output_path
adsl_output_path
adeff_output_path
table_one_output_path
primary_endpoint_table_output_path
treatment_difference_output_path
exploratory_ttest_output_path
report_output_path
auto_accept_threshold
manual_overrides
endpoint definition
```

This changed the project from a hard-coded demo script into a config-driven pipeline

---

### 2. Added Config Loader

Created

```text
src/config/config_loader.py
```

Implemented functions

```text
load_config
get_path
get_auto_accept_threshold
get_manual_overrides
get_endpoint_config
```

Purpose

```text
Load pipeline settings from config.yaml
Validate required endpoint configuration
Provide reusable config access functions for main.py
```

---

### 3. Added Endpoint Configuration

Added endpoint settings to

```text
config.yaml
```

Current endpoint

```text
Change from baseline in systolic blood pressure
```

Current endpoint config

```yaml
endpoint:
  primary_endpoint_name: "Change from baseline in systolic blood pressure"
  baseline_variable: "BASELINE"
  analysis_variable: "AVAL"
  treatment_variable: "TRT01P"
  active_group: "Drug A"
  control_group: "Placebo"
  alpha: 0.05
```

This endpoint is derived from the confirmed ADSL-like variables

```text
BASELINE
AVAL
TRT01P
```

---

### 4. Added ADEFF-like Dataset Builder

Created

```text
src/efficacy/adeff_builder.py
```

Implemented functions

```text
build_adeff_like_dataset
save_adeff_like_dataset
```

The ADEFF-like dataset is derived from the ADSL-like dataset

Current derivation logic

```text
BASE = BASELINE
AVAL = post-baseline analysis value
CHG = AVAL - BASE
PCHG = CHG / BASE × 100
```

Generated output

```text
data/adam_like/adeff_demo.csv
```

Current ADEFF-like variables

```text
SUBJID
TRT01P
PARAM
BASE
AVAL
CHG
PCHG
```

---

### 5. Added Primary Endpoint Summary Table

Created

```text
src/tlfs/primary_endpoint_table.py
```

Implemented functions

```text
summarize_endpoint_by_group
save_primary_endpoint_table
```

Generated output

```text
outputs/tables/primary_endpoint_table_demo.csv
```

Current primary endpoint summary

| Group | N | Mean CHG | SD CHG | Mean PCHG | SD PCHG |
|---|---:|---:|---:|---:|---:|
| Drug A | 3 | -18.33 | 1.53 | -11.89 | 0.67 |
| Placebo | 2 | -4.00 | 1.41 | -2.63 | 0.85 |
| Overall | 5 | -12.60 | 7.96 | -8.19 | 5.11 |

---

### 6. Added Treatment Difference Table

Created

```text
src/efficacy/treatment_difference.py
```

Implemented functions

```text
calculate_treatment_difference
save_treatment_difference_table
```

Generated output

```text
outputs/tables/treatment_difference_demo.csv
```

Current descriptive treatment difference

```text
Drug A Mean CHG = -18.33
Placebo Mean CHG = -4.00
Mean CHG Difference = -14.33
```

Interpretation boundary

```text
Descriptive only
Not confirmatory
No statistical inference was performed
```

This prevents the system from overstating treatment effectiveness

---

### 7. Added Exploratory Welch t-test

Created

```text
src/efficacy/statistical_tests.py
```

Implemented functions

```text
welch_ttest_chg
save_exploratory_ttest_table
```

Generated output

```text
outputs/tables/exploratory_ttest_demo.csv
```

The exploratory t-test output includes

```text
analysis type
active group
control group
active N
control N
active mean CHG
control mean CHG
mean CHG difference
standard error
degrees of freedom
t statistic
p-value
confidence interval
interpretation boundary
```

Current exploratory result

```text
Mean CHG Difference = -14.33
95% CI = -19.2 to -9.46
Exploratory p-value = 0.0042
```

Important limitation

```text
This is exploratory only
The dataset is synthetic
The sample size is very small
The result must not be interpreted as confirmatory evidence
```

---

### 8. Updated Mini CSR-style Report Writer

Updated

```text
src/report/mini_csr_writer.py
```

The report now includes efficacy results

New report sections

```text
Primary Endpoint Descriptive Summary
Exploratory Statistical Addendum
```

The Primary Endpoint Descriptive Summary reports

```text
primary endpoint definition
Drug A mean CHG
Placebo mean CHG
Drug A mean PCHG
Placebo mean PCHG
descriptive mean CHG difference
descriptive mean PCHG difference
descriptive-only interpretation boundary
```

The Exploratory Statistical Addendum reports

```text
Welch two-sample t-test
mean CHG difference
95% confidence interval
exploratory p-value
not-confirmatory interpretation boundary
```

The report avoids confirmatory language such as

```text
Drug A is effective
Drug A significantly improves systolic blood pressure
Treatment efficacy was proven
```

Instead it uses controlled wording such as

```text
observed descriptive difference
exploratory comparison
not confirmatory
synthetic demo dataset
very small sample size
```

---

### 9. Upgraded Traceability Section

Updated the mini CSR-style report traceability section

The report now lists all major pipeline outputs

```text
Mapping configuration
Mapping QC report
Data quality report
ADSL-like dataset
ADEFF-like dataset
Table 1
Primary endpoint table
Treatment difference table
Exploratory t-test table
```

This improves audit readiness by connecting report content to generated evidence files

---

### 10. Cleaned Report Formatting

Updated report generation to clean multiline string formatting

Added

```text
textwrap.dedent
```

Purpose

```text
Remove unwanted indentation in generated markdown
Improve report readability
Keep markdown output clean
```

---

## Output Files Generated

| Output | Path |
|---|---|
| Mapping config | outputs/audit_logs/mapping_config_demo.json |
| Mapping QC report | outputs/audit_logs/mapping_qc_report_demo.csv |
| Data quality report | outputs/audit_logs/data_quality_report_demo.csv |
| ADSL-like dataset | data/adam_like/adsl_demo.csv |
| ADEFF-like dataset | data/adam_like/adeff_demo.csv |
| Table 1 | outputs/tables/table_one_demo.csv |
| Primary endpoint table | outputs/tables/primary_endpoint_table_demo.csv |
| Treatment difference table | outputs/tables/treatment_difference_demo.csv |
| Exploratory t-test table | outputs/tables/exploratory_ttest_demo.csv |
| Mini CSR-style report | outputs/reports/mini_csr_report_demo.md |

---

## Current Statistical Interpretation Boundary

The current efficacy output is not confirmatory

The current dataset is synthetic and includes only five subjects

Therefore the report must be interpreted as a technical pipeline demonstration only

The project currently supports

```text
descriptive endpoint summaries
descriptive treatment differences
exploratory statistical comparison
controlled non-confirmatory reporting language
```

The project does not yet support

```text
confirmatory clinical inference
formal SAP-driven analysis
multiplicity adjustment
regulatory-grade statistical validation
production CDISC compliance
```

---

## Key Technical Principle Implemented

Day 3 introduced the first efficacy analysis layer

```text
ADSL-like dataset
→ ADEFF-like dataset
→ endpoint derivation
→ endpoint summary
→ treatment difference
→ exploratory statistical comparison
→ CSR-style narrative
```

This follows a more clinically appropriate structure than directly analyzing raw data

---

## Main Files Added or Modified

| File | Purpose |
|---|---|
| config.yaml | Stores paths thresholds overrides and endpoint settings |
| src/config/config_loader.py | Loads and validates pipeline configuration |
| src/efficacy/adeff_builder.py | Builds ADEFF-like efficacy dataset |
| src/tlfs/primary_endpoint_table.py | Generates endpoint summary table |
| src/efficacy/treatment_difference.py | Calculates descriptive treatment difference |
| src/efficacy/statistical_tests.py | Runs exploratory Welch t-test |
| src/report/mini_csr_writer.py | Adds efficacy narrative statistical addendum and traceability |
| main.py | Runs config-driven end-to-end pipeline |

---

## Final Day 3 Summary

Day 3 upgraded the project from an audit-aware mapping pipeline into a config-driven efficacy analysis reporting prototype

Day 1 proved the system could run end to end  
Day 2 made the system reviewable and audit-aware  
Day 3 made the system configurable and added the first efficacy analysis layer

---

## Recommended Next Step

The recommended next step is to start the safety analysis layer

Potential Day 4 objective

```text
Build ADAE-like dataset prototype
Define TEAE logic
Generate first safety summary table
Add safety section to CSR-style report
```

Reason

```text
A medical report cannot be top-tier if it only reports efficacy
It must also include safety
```
